| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| efsa peer review fenpropidin | 0.55 | 0.5 | 8999 | 82 | 28 |
| efsa | 1.04 | 0.5 | 1115 | 51 | 4 |
| peer | 1.04 | 0.5 | 3631 | 39 | 4 |
| review | 0.53 | 0.3 | 9143 | 83 | 6 |
| fenpropidin | 1.51 | 0.5 | 2603 | 65 | 11 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| efsa peer review fenpropidin | 1.91 | 0.1 | 1327 | 45 |
| efsa peer review azoxystrobin | 0.52 | 0.4 | 6035 | 23 |
| efsa peer review diflufenican | 0.14 | 0.8 | 90 | 86 |
| saflufenacil efsa peer review | 0.04 | 0.4 | 2362 | 42 |
| efsa peer review cyazofamid | 1.15 | 0.6 | 1322 | 66 |
| efsa conclusion on the peer review | 1.43 | 0.7 | 4658 | 77 |
| efsa peer review acequinocyl | 0.36 | 0.3 | 4602 | 36 |
Fenpropidin is one of the 79 substances of the third stage Part A of the review programme covered by Commission Regulation (EC) No 1490/20021. This Regulation requires the European Food Safety Authority (EFSA) to organise a peer review of the initial evaluation, i.e. the draft assessment report
What is fenpropidin?SUMMARY Fenpropidin is one of the 79 substances of the third stage Part A of the review programme covered by Commission Regulation (EC) No 1490/20021. This Regulation requires the European Food Safety Authority (EFSA) to organise a peer review of the initial evaluation, i.e. the draft assessment report
What is the consumer risk assessment of fenpropidin?CONSUMER RISK ASSESSMENT No risk for the consumer is expected resulting from the use of fenpropidin according to the representative uses. The risk assessment was performed disregarding the possible impact of a change of the enantiomer ratio due to plant or livestock metabolism as this was not investigated by the notifier.
Do different isomer ratios affect the exposure assessment of fenpropidin?• Impact of different isomer ratios on the exposure assessment of fenpropidin for operator, worker and bystander is to be addressed (relevant for all applied for intended uses; data gap identified by EFSA after the expert meeting; no submission date proposed; refer to point 2.12).
